BioSpace News Archive

Asieris Pharmaceuticals (Asieris), announced today it has received Clinical Trial Approval (CTA) from China’s National Medical Products Administration (NMPA) for the global, multi-centered Phase III clinical trial of its photodynamic drug-device combination product, APL-1702 (Cevira®

The U.S. Department of Agriculture (USDA) has awarded Boehringer Ingelheim a contract to help supply a vaccine bank that will protect U.S. livestock from foot-and-mouth disease.

Saladax Biomedical Inc., announced that the FDA has granted their De Novo Request for a rapid blood test that measures clozapine levels in psychiatric patients.

Quanta, Inc. (OTC PINK:QNTA), an applied sciences company based on a quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, today announced another virtual “Town Hall” style investor event, which will be broadcast live over the internet on July 15, 2020 at 1:30 PM ET / 10:30 AM PT.

ONCOLOGY® and CancerNetwork®, a multispecialty platform focused on bringing practical, peer-reviewed content that can affect how oncologists, oncology nurses and other relevant health care professionals treat their patients, are excited to announce the addition of six tumor chairs to the editorial advisory board.

TARA Biosystems today reported study results demonstrating the ability of TARA’s in vitro human cardiac models to reproduce drug responses similar to those observed in humans

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2020 financial and operating results on Wednesday, August 5, 2020, before the U.S. financial markets open

Eisai Co., Ltd. announced today that the new drug application for approval of its in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance, has been accepted by the Hong Kong Department of Health.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Deborah H. Telman as General Counsel for Organon & Co., its intended spinoff of its women’s health, legacy brands and biosimilars businesses.

Biogen Inc. (Nasdaq: BIIB) today announced that positive results from a Phase 1/2 study of tofersen (BIIB067) for the potential treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS) were published in TheNew England Journal of Medicine.